申请人:Linden Joel
公开号:US20050027125A1
公开(公告)日:2005-02-03
The present invention relates generally to a class of 2-aminothiazole derivatives which have recently been identified as allosteric enhancers of the A
1? adenosine receptor. These compounds, and therapeutic compositions containing them, are useful for treating conditions in which activation of the A
1? adenosine receptor would be beneficial, for example, those conditions in which stimulation of angiogenesis would improve blood flow to ischemic tissues.
本发明总体上涉及一类 2-氨基噻唑衍生物,这些衍生物最近被鉴定为 A
1?这些化合物以及含有它们的治疗组合物可用于治疗激活 A 1?
1? 腺苷受体将是有益的,例如,刺激血管生成将改善缺血组织的血流量。